Chennai, February 02 2017:TAKE Solutions Ltd. [BSE: 532890 | NSE: TAKE], a globally recognized knowledge and innovation intensive Life Sciences expert, today announced the financial results for the third quarter FY 2017. The company reported revenue of INR 3,431 Mn, a 38.4% growth over the corresponding period in the previous year. The Net profit was reported at INR 322 Mn, a 34.3% increase over corresponding period in the previous year.

Key highlights:

  • The company embarked on a 5-year transformational scale-up plan with a mission to significantly magnify its size and scale, amplifying its revenues by 5x to emerge as a 500 Mn USD enterprise.
  • The Q3 FY17 order-book registered a substantial growth of 13% over the previous quarter with the addition of 14 new clients across USA and Asia.
  • The company announced the appointment of Ms. Subhasri Sriram as Chief Finance Officer. Ms. Sriram, who brings with her 25 years of experience, is a recipient of the 'Best Performing CFO in the NBFC Sector' award instituted by CNBC TV18.

Srinivasan H.R., Vice-Chairman and Managing Director, TAKE Solutions said, 'We have witnessed a rewarding quarter, sustained by our efforts towards strengthening our position as a full-service boutique Life Sciences company. The growth in our order book stands testimony to our growth trajectory.'

He further added, 'We are excited to have embarked on a journey of reinvention which will see us amalgamate our strengths across our geographies and brands to emerge as a 500 Mn USD enterprise by 2021. We are also immensely pleased to welcome Ms. Subhasri Sriram as our Chief Finance Officer, whose invaluable leadership and industry experience will add tremendous value to the organization as we jointly progress towards our goal.'

About TAKE Solutions

TAKE Solutions is a globally recognized knowledge intensive, technology enabled player, delivering comprehensive and niche solutions for enterprises across diverse sectors for over 15 years, with key expertise in Life Sciences (LS). In this domain, TAKE offers IP-based software and extensive knowledge-based solutions to enable efficient clinical, regulatory, safety and content management. TAKE encompasses specialized lines of businesses under distinct brands such as Navitas - an IP driven Life Sciences solutions company, Ecron Acunova - a specialized provider of Clinical Services to both Pharma & Biotech companies, Intelent - an expert in Life Sciences Big Data, TAKE Supply Chain & TAKE MEA - flexible, accessible, mobile Supply Chain software solution providers, APA Engineering - an International e-Sourcing and Engineering services company, TAKE Innovations - an incubator to facilitate IP Creation and TAKE Enterprise Services Inc. - a specialist provider of technology-driven business solutions and software services.

TAKE's significant recognitions include a patent win from the United States Patent and Trademark Office (USPTO) for its 'Method for Optimizing Clinical Data Standardization', a 'Leader' certification in Drug Safety Services & Life Sciences R&D IT Outsourcing from IDC, recognition as the 'Dream Employer of the Year' at the World HRD Congress, the title of 'Most Admired Brand-IT' from the Asian Customer Engagement Forum and a Special Commendation for excellence in Corporate Governance from the Golden Peacock Awards. With its global headquarters in Chennai, India, TAKE has a proven track record of delivering world-class solutions to more than 400 customers worldwide, including 9 of the top 10 global Pharma companies. For more information, please visit www.takesolutions.com.

Contacts::
Samhita Suresh, TAKE Solutions, +91 44 66110700, samhita.suresh@takesolutions.com
Murugan G, 20:20 MSL, +91 9841278904, murugan.g@2020msl.com


Take Solutions Limited published this content on 02 February 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 02 February 2017 13:04:09 UTC.

Original documenthttp://www.takesolutions.com/take-solutions-reports-strong-q3-fy-17-revenue-of-inr-3-431-mn

Public permalinkhttp://www.publicnow.com/view/CECEBFAF7B2547C22E7250F52E7DF273D24051DF